Tobacco Treatment Program

Rationale

BHCS recognizes that tobacco dependence is a prevalent co-occurring condition that warrants special treatment focus and provider staff training. BHCS is committed to taking a leadership role as we move to integrate tobacco treatment interventions into all BHCS programs.
Rationale:

  • Tobacco dependence treatment will help reduce the current 25 year mortality gap among the Seriously Mentally Ill. (Manderscheid and Colton, Preventing Chronic Disease, April 2006). It is estimated that 40% of this mortality gap can be attributed to deaths due to tobacco-related diseases – particularly heart and lung disease, stroke and diabetes.
  • 60-90% of substance abuse and mental health clients smoke. The current smoking prevalence in CA is 13%. (Lasser, JAMA, Nov. 2000; CA Tobacco Control Section, 2006)
  • 44% of tobacco marketed in the US is consumed by people with substance abuse and mental health diagnoses. (Lasser, JAMA, Nov. 2000)
  • Nicotine is a drug as addictive as heron.
  • Assessing and treating tobacco dependence is consistent with the mission of BHCS to “maximize the recovery, resilience and wellness of all eligible Alameda County residents who are developing or experiencing serious mental health, alcohol or drug concerns.”